Debanjana Chatterjee
Stock Analyst at Jones Trading
(3.58)
# 860
Out of 5,044 analysts
11
Total ratings
70%
Success rate
20.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Initiates: Buy | $46 | $37.25 | +23.49% | 1 | Sep 8, 2025 | |
| TBPH Theravance Biopharma | Initiates: Buy | $24 | $14.12 | +69.97% | 1 | Jun 17, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Buy | $15 → $27 | $8.33 | +224.13% | 2 | Jun 6, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Buy | $39 | $4.72 | +726.27% | 1 | Apr 28, 2025 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $30 | $10.98 | +173.22% | 2 | Mar 26, 2025 | |
| CTNM Contineum Therapeutics | Initiates: Buy | $23 | $10.79 | +113.16% | 1 | Mar 13, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Hold | n/a | $23.85 | - | 1 | Dec 11, 2024 | |
| PHVS Pharvaris | Initiates: Buy | $46 | $22.03 | +108.81% | 1 | Sep 19, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Buy | $41 | $13.12 | +212.62% | 1 | Sep 17, 2024 |
Sionna Therapeutics
Sep 8, 2025
Initiates: Buy
Price Target: $46
Current: $37.25
Upside: +23.49%
Theravance Biopharma
Jun 17, 2025
Initiates: Buy
Price Target: $24
Current: $14.12
Upside: +69.97%
Sagimet Biosciences
Jun 6, 2025
Maintains: Buy
Price Target: $15 → $27
Current: $8.33
Upside: +224.13%
Tvardi Therapeutics
Apr 28, 2025
Initiates: Buy
Price Target: $39
Current: $4.72
Upside: +726.27%
KalVista Pharmaceuticals
Mar 26, 2025
Maintains: Buy
Price Target: $30
Current: $10.98
Upside: +173.22%
Contineum Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $23
Current: $10.79
Upside: +113.16%
Spyre Therapeutics
Dec 11, 2024
Initiates: Hold
Price Target: n/a
Current: $23.85
Upside: -
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $22.03
Upside: +108.81%
Intellia Therapeutics
Sep 17, 2024
Initiates: Buy
Price Target: $41
Current: $13.12
Upside: +212.62%